查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球醫療保健分析市場：按類型(描述性,預測性,認知性),應用程序(金融,RCM,欺詐,臨床,操作),組件(服務,軟件),部署方法(本地,雲端),用戶(醫院,付款人)預測至2027
市場調查報告書
商品編碼
1177332

全球醫療保健分析市場：按類型(描述性,預測性,認知性),應用程序(金融,RCM,欺詐,臨床,操作),組件(服務,軟件),部署方法(本地,雲端),用戶(醫院,付款人)預測至2027

Healthcare Analytics Market by Type (Descriptive, Predictive, Cognitive), Application (Financial, RCM, Fraud, Clinical, Operational), Component (Services, Software), Deployment (on premise, Cloud), End-user (Hospitals, Payer) - Global Forecast to 2027
出版日期: | 出版商: MarketsandMarkets | 英文 323 Pages | 訂單完成後即時交付

價格
簡介目錄

全球醫療分析市場預計將從 2022 年的 274 億美元增長到 2027 年的 859 億美元，預測期內復合年增長率為 25.7%。

市場增長的主要推動因素是風險資本投資的增加和聯邦衛生要求加速採用醫療 IT 解決方案。 另一方面，IT 基礎設施連接性差、數據安全問題以及醫院部署醫療 IT 解決方案的預算分配低可能會抑制市場增長。

按類型劃分，描述性分析部分將在 2021 年佔據最大份額。 這是因為描述性分析有助於增強和管理付款人和提供者的績效。

按應用劃分，財務分析將在 2021 年佔據最大份額，而臨床分析領域預計在預測期內將以最高複合年增長率增長。

按組成部分劃分，服務領域將在 2021 年佔據最大的市場份額。 這是由於最終用戶依賴服務提供商提供諮詢、數據存儲、實施服務和定期解決方案更新。

到 2022 年，本地類型預計將按部署方式佔據最大份額。 這背後的原因是本地部署使最終用戶可以訪問來自多個供應商的解決方案，並允許根據最終用戶的要求進行定制。

按最終用戶劃分，支付部門將在 2021 年佔據最大份額。 控制欺詐性索賠和最小化運營成本的需求不斷增長，是推動該細分市場增長的主要因素。

按地區劃分，北美(包括美國和加拿大)將在 2021 年佔據最大的市場份額。 造成這種情況的因素包括許多大公司的總部都設在北美、技術進步以及該地區產品和服務的高可用性。

本報告按類型、組件、部署方法、應用程序和最終用戶分析了全球醫療分析市場，包括市場的基本結構和最新發展、主要市場驅動因素和製約因素。我們是按地區調查市場趨勢前景、市場競爭狀況和主要公司概況。

內容

第一章介紹

第二章研究方法論

第 3 章執行摘要

第 4 章重要注意事項

第 5 章市場概述

  • 簡介
  • 市場動態
    • 司機
    • 約束因素
    • 機會
    • 任務
  • 生態系統分析
  • 價值鏈分析
  • 案例研究分析
  • 波特的五力分析
  • 監管分析
  • 技術分析
    • 機器學習 (ML)
    • 人工智能 (AI)
    • IoT(物聯網)
    • 區塊鏈
    • 大數據
  • 行業趨勢
    • 加強夥伴關係和創新協作
    • 將風險從付款人轉移到供應商
    • 基於雲的 IT 解決方案
  • 價格分析
  • 平均售價趨勢分析
  • 專利分析
  • 主要會議和活動 (2022-2023)
  • 主要利益相關者和採購標準

第 6 章。醫療分析市場：按類型

  • 簡介
  • 描述性分析
  • 預測分析
  • 規範分析
  • 認知分析

第 7 章醫學分析市場：按組件分類

  • 簡介
  • 服務
    • 支持服務
    • 商業分析 (BA) 服務
  • 軟件
  • 硬件

第 8 章醫療分析市場：按部署方法

  • 簡介
  • 本地部署
  • 按需部署

第 9 章醫療分析市場：按應用

  • 簡介
  • 財務分析
    • 計費流程
    • 收入周期管理
    • 支付完整性、FWA(欺詐、浪費和濫用)
    • 風險調整/評估
  • 臨床分析
    • 質量改進/臨床基準
    • 臨床決策支持
    • 報告/合規
    • 比較分析/效果
    • 精準醫療
    • 醫學影像分析
  • 運營和管理分析 (RCM)
    • 供應鏈分析
    • 勞動力分析
    • 戰略分析
  • 人口健康分析

第 10 章醫療分析市場：最終用戶

  • 簡介
  • 付款人
    • 私人保險公司
    • 政府機構
    • 雇主/私人交易所
  • 醫療保健提供者
    • 醫院/診所/IDN
    • 後急性治療機構
    • 門診設施
  • ACO□HIE□MCO□TPA

第 11 章醫療分析市場：按地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞洲
    • 日本
    • 中國
    • 印度
    • 其他亞洲國家
  • 太平洋國家
  • 拉丁美洲
  • 中東和非洲

第12章競爭格局

  • 簡介
  • 主要公司採用的策略
  • 主要公司的收入份額分析
  • 市場排名分析(2021 年)
  • 企業領導力測繪
  • 競爭領導力映射：初創公司/中小企業 (2021)
  • 競爭基準
  • 競爭場景
    • 產品發布和批准
    • 資本交易
    • 其他趨勢

第13章公司簡介

  • 主要公司
    • IBM
    • SAS INSTITUTE INC.
    • OPTUM, INC.
    • CERNER CORPORATION
    • ALLSCRIPTS HEALTHCARE, LLC
    • COTIVITI, INC.
    • CITIUSTECH INC.
    • HEALTH CATALYST
    • CVS HEALTH
    • INOVALON
    • MCKESSON CORPORATION
    • MEDEANALYTICS, INC.
    • ORACLE
    • EXLSERVICE HOLDINGS, INC.
    • GAINWELL.
    • WIPRO
  • 其他企業
    • FLATIRON
    • APIXIO
    • ENLITIC, INC.
    • KOMODO HEALTH, INC.
    • HEALTHEC, LLC
    • SEMA4 OPCO, INC.
    • EVIDATION HEALTH, INC.
    • INSILICO MEDICINE
    • EXSCIENTIA
    • AETION, INC.
    • PREMIER

第14章 附錄

簡介目錄
Product Code: HIT 2180

The global healthcare analytics market is projected to reach USD 85.9 billion by 2027 from USD 27.4 billion in 2022, at a CAGR of 25.7% during the forecast period. The healthcare analytics market is mainly driven by factors such as increasing amount of venture capital investments and implementation of federal health mandates that encourage the adoption of HCIT solutions. However, poorly connected IT infrastructure, data security issues, and low budget allocations of hospitals for implementing HCIT solutions are likely to restrain growth of this market.

Descriptive analytics type segment holds the largest share of the healthcare analytics market in 2021"

On the basis of type, the market is segmented into cognitive analytics, descriptive analytics, predictive analytics, and prescriptive analytics. In 2021, the descriptive analytics segment hold the largest share of the healthcare analytics market. The large share of this segment is primarily attributed because descriptive analytics help healthcare payers and providers to enhance and manage their business practices.

Clinical analytics segment is expected to grow at the highest rate during the forecast period

On the basis of application, the healthcare analytics market is segmented into financial analytics, clinical analytics, operational & administrative analytics, and population health analytics. In 2021, the financial analytics segment hold the largest share of the healthcare analytics market, while the clinical analytics segment is projected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing pressure to curb healthcare costs, and federal mandates such as the implementation of ICD-10 code sets.

Services segment to hold the largest share of the healthcare analytics market

On the basis of component, the healthcare analytics market is segmented into services, hardware, and software. In 2021, the services segment accounted for the largest market share of healthcare analytics market. Factors such as end users of healthcare analytics depend on service providers for consulting, data storage, implementing services, and regular solution upgrades.

On-premise segment is expected to account for the largest share of the healthcare analytics market

On the basis of deployment model, the market is segmented into on-premise and on-demand. In 2022, on-premise segment is estimated to account for the largest share of the healthcare analytics market. The large share of this segment is primarily attributed because on-premise deployment allows end users to make use of solutions from multiple vendors, which allows customizations as per end-user requirements.

Payers segments hold the largest share of the healthcare analytics in 2021, by end user

On the basis of end users, the healthcare analytics market is segmented into providers (hospitals, physician practices, IDN, post-acute care organisations and, ambulatory settings), payers (private insurance companies, government agencies, and employers & private exchangers), and ASCOs, HIEs, & TPAs. In 2021, the payers segment holds the largest share of the healthcare analytics market. Factors such as the increasing need to curb fraudulent claims and minimize the operational price is the key factor driving the growth of this segment.

North America to be the largest and the fastest-growing regional market

North America, which includes the US and Canada, holds the largest market share for healthcare analytics market in 2021. Factors such as most of the leading players in the healthcare analytics market have their headquarters in North America, technological advancements, and high product and service availability in this region.

Breakdown of supply-side primary interviews: * By Company Type: Tier 1 - 37%, Tier 2 - 22%, and Tier 3 - 41% * By Designation: Director-level - 25%, C-level - 20%, and Others - 55% * By Region: North America - 40%, Europe - 27%, APAC -20%, Rest of the World -13%

Prominent players in this market include IBM (US), SAS Institute Inc. (US), Optum, Inc. (US), Cerner Corporation (US), Allscripts Healthcare, LLC (US), Cotiviti, Inc. (US), CitiusTech Inc (US), Health Catalyst (US), CVS Health (US), Inovalon (US), McKesson Corporation (US), MedeAnalytics, Inc. (US), Oracle (US), ExlService Holdings, Inc. (US), Gainwell (US), Wipro (US), Flatiron (US), Apixio (US), Enlitic, Inc. (US), Komodo Health, Inc. (US), HealthEC, LLC, Sema4 OpCo, Inc. (US), Evidation Health, Inc. (US), Insilico Medicine (US), Exscientia (UK), Aetion, Inc.(US), and Premier (US).

Research Coverage

This report studies the healthcare analytics market based on type, application, component, deployment model, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to two main geographies - source and destination.

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 HEALTHCARE ANALYTICS MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED
  • 1.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
  • 2.2 RESEARCH METHODOLOGY DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Insights from primary experts
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
    • FIGURE 7 REVENUE ANALYSIS OF TOP THREE PUBLIC COMPANIES: HEALTHCARE ANALYTICS MARKET (2021)
    • FIGURE 8 BOTTOM-UP APPROACH: END-USER ADOPTION/CONSUMPTION OF HEALTHCARE ANALYTICS (US)
    • FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022-2027)
    • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 11 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 12 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: HEALTHCARE ANALYTICS MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 13 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 14 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 15 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 16 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2022 VS. 2027 (USD MILLION)
    • FIGURE 17 HEALTHCARE ANALYTICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 18 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE ANALYTICS MARKET

4 PREMIUM INSIGHTS

  • 4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW
    • FIGURE 19 GOVERNMENT INITIATIVES TO INCREASE EHR ADOPTION AND CURB HEALTHCARE COSTS
  • 4.2 FINANCIAL ANALYTICS MARKET SHARE, BY TYPE AND REGION (2021)
    • FIGURE 20 NORTH AMERICA HELD LARGEST SHARE OF FINANCIAL ANALYTICS MARKET IN 2021
  • 4.3 HEALTHCARE ANALYTICS MARKET: GROWTH RATES
    • FIGURE 21 US TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.4 REGIONAL MIX: HEALTHCARE ANALYTICS MARKET
    • FIGURE 22 NORTH AMERICA DOMINATED MARKET IN 2021

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 23 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Government initiatives to increase EHR adoption
    • FIGURE 24 EHR ADOPTION RATE AMONG HOSPITALS AND PHYSICIANS (2015-2021)
      • 5.2.1.2 Growing venture capital investments in healthcare analytics start-ups
      • 5.2.1.3 Growing pressure to curb healthcare spending and improve patient outcomes
    • FIGURE 25 HEALTHCARE SPENDING AS PERCENTAGE OF GDP, BY COUNTRY, 2019
      • 5.2.1.4 Heterogeneity and complexity of big data in healthcare
      • 5.2.1.5 Growing focus on real-world evidence
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of analytics solutions in healthcare organizations
      • 5.2.2.2 Rising data breach concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing focus on value-based medicines
      • 5.2.3.2 Use of analytics in precision and personalized medicines
      • 5.2.3.3 Cloud-based analytics
      • 5.2.3.4 Increasing number of patient registries
      • 5.2.3.5 Emergence of social media and its impact on healthcare industry
      • 5.2.3.6 Augmented analytics to supplement human intelligence
      • 5.2.3.7 Growing adoption of internet of healthcare things (IoHT)
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Concerns regarding inaccurate and inconsistent data
      • 5.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries
      • 5.2.4.3 Data integration for coordinated care
      • 5.2.4.4 Operational gaps between payers and providers
      • 5.2.4.5 Dearth of skilled personnel
  • 5.3 ECOSYSTEM ANALYSIS
    • FIGURE 26 ECOSYSTEM ANALYSIS: HEALTHCARE ANALYTICS MARKET
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 27 VALUE CHAIN ANALYSIS: HEALTHCARE ANALYTICS MARKET
  • 5.5 CASE STUDY ANALYSIS
    • 5.5.1 CASE STUDY 1
    • 5.5.2 CASE STUDY 2
    • 5.5.3 CASE STUDY 3
    • 5.5.4 CASE STUDY 4
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 PORTER'S FIVE FORCES ANALYSIS: HEALTHCARE ANALYTICS MARKET
    • 5.6.1 THREAT FROM NEW ENTRANTS
    • 5.6.2 THREAT FROM SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 REGULATORY ANALYSIS
    • 5.7.1 NORTH AMERICA
    • 5.7.2 EUROPE
    • 5.7.3 ASIA PACIFIC
    • 5.7.4 MIDDLE EAST & AFRICA
    • 5.7.5 LATIN AMERICA
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 MACHINE LEARNING
    • 5.8.2 ARTIFICIAL INTELLIGENCE
    • 5.8.3 INTERNET OF THINGS
    • 5.8.4 BLOCKCHAIN
    • 5.8.5 BIG DATA
  • 5.9 INDUSTRY TRENDS
    • 5.9.1 INCREASING PARTNERSHIPS AND COLLABORATIONS FOR INNOVATION
    • 5.9.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
    • 5.9.3 CLOUD-BASED IT SOLUTIONS
  • 5.10 PRICING ANALYSIS
    • TABLE 3 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY APPLICATION
  • 5.11 AVERAGE SELLING PRICE TREND ANALYSIS
  • 5.12 PATENT ANALYSIS
    • FIGURE 28 PATENT ANALYSIS: HEALTHCARE ANALYTICS MARKET (JANUARY 2017-SEPTEMBER 2022)
    • 5.12.1 PATENTS: HEALTHCARE ANALYTICS MARKET
  • 5.13 KEY CONFERENCES AND EVENTS IN 2022-2023
    • TABLE 4 HEALTHCARE ANALYTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
    • TABLE 5 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
    • 5.14.2 BUYING CRITERIA
    • FIGURE 30 KEY BUYING CRITERIA FOR END USERS
    • TABLE 6 KEY BUYING CRITERIA FOR END USERS

6 HEALTHCARE ANALYTICS MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 7 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 6.2 DESCRIPTIVE ANALYTICS
    • 6.2.1 DESCRIPTIVE ANALYTICS TO CONVERT PAST DATA INTO USEFUL INFORMATION
    • TABLE 8 HEALTHCARE ANALYTICS MARKET FOR DESCRIPTIVE ANALYTICS, BY REGION, 2020-2027 (USD MILLION)
  • 6.3 PREDICTIVE ANALYTICS
    • 6.3.1 GROWING USE OF PREDICTIVE ANALYTICS TO IDENTIFY HIGH-RISK PATIENTS TO DRIVE GROWTH
    • TABLE 9 HEALTHCARE ANALYTICS MARKET FOR PREDICTIVE ANALYTICS, BY REGION, 2020-2027 (USD MILLION)
  • 6.4 PRESCRIPTIVE ANALYTICS
    • 6.4.1 PRESCRIPTIVE ANALYTICS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    • TABLE 10 HEALTHCARE ANALYTICS MARKET FOR PRESCRIPTIVE ANALYTICS, BY REGION, 2020-2027 (USD MILLION)
  • 6.5 COGNITIVE ANALYTICS
    • 6.5.1 INTRODUCTION OF AI-DRIVEN ANALYTICS SOLUTIONS TO BOOST MARKET
    • TABLE 11 HEALTHCARE ANALYTICS MARKET FOR COGNITIVE ANALYTICS, BY REGION, 2020-2027 (USD MILLION)

7 HEALTHCARE ANALYTICS MARKET, BY COMPONENT

  • 7.1 INTRODUCTION
    • TABLE 12 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
  • 7.2 SERVICES
    • TABLE 13 HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 14 HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY REGION, 2020-2027 (USD MILLION)
    • 7.2.1 SUPPORT SERVICES
      • 7.2.1.1 Support services to include implementation, ongoing IT support, system integration, training, and maintenance services
    • TABLE 15 HEALTHCARE ANALYTICS SUPPORT SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 7.2.2 BUSINESS ANALYTICS SERVICES
      • 7.2.2.1 Business analytics services to help healthcare organizations optimize use of analytics and drive performance improvement
    • TABLE 16 HEALTHCARE BUSINESS ANALYTICS SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 7.3 SOFTWARE
    • 7.3.1 HEALTHCARE ANALYTICS SOFTWARE TO WORK AS INTERFACE BETWEEN DATABASE AND END USERS
    • TABLE 17 HEALTHCARE ANALYTICS MARKET FOR SOFTWARE, BY REGION, 2020-2027 (USD MILLION)
  • 7.4 HARDWARE
    • 7.4.1 INCREASING ADOPTION OF CLOUD SERVERS TO HINDER GROWTH
    • TABLE 18 HEALTHCARE ANALYTICS MARKET FOR HARDWARE, BY REGION, 2020-2027 (USD MILLION)

8 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL

  • 8.1 INTRODUCTION
    • TABLE 19 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
  • 8.2 ON-PREMISE DEPLOYMENT
    • 8.2.1 MULTIVENDOR ARCHITECTURE TO LOWER RISK OF DATA BREACHES AND EXTERNAL ATTACKS
    • TABLE 20 ON-PREMISE SOLUTIONS AVAILABLE
    • TABLE 21 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE DEPLOYMENT MODEL, BY REGION, 2020-2027 (USD MILLION)
  • 8.3 ON-DEMAND DEPLOYMENT
    • 8.3.1 INCREASING VOLUME OF DATA GENERATED TO DRIVE ADOPTION
    • TABLE 22 ON-DEMAND SOLUTIONS AVAILABLE
    • TABLE 23 HEALTHCARE ANALYTICS MARKET FOR ON-DEMAND DEPLOYMENT MODEL, BY REGION, 2020-2027 (USD MILLION)

9 HEALTHCARE ANALYTICS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 24 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 9.2 FINANCIAL ANALYTICS
    • TABLE 25 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS
    • TABLE 26 HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 27 HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY REGION, 2020-2027 (USD MILLION)
    • 9.2.1 CLAIMS PROCESSING
      • 9.2.1.1 Improvement in claims response time and avoidance of fraudulent claims to support market
    • TABLE 28 COMMERCIALLY AVAILABLE CLAIMS PROCESSING SOLUTIONS
    • TABLE 29 HEALTHCARE ANALYTICS MARKET FOR CLAIMS PROCESSING, BY REGION, 2020-2027 (USD MILLION)
    • 9.2.2 REVENUE CYCLE MANAGEMENT
      • 9.2.2.1 Healthcare organizations to adopt predictive analytics solutions for proactive decision-making
    • TABLE 30 COMMERCIALLY AVAILABLE REVENUE CYCLE MANAGEMENT SOLUTIONS
    • TABLE 31 HEALTHCARE ANALYTICS MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2020-2027 (USD MILLION)
    • 9.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE (FWA)
      • 9.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems to boost market
    • TABLE 32 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS
    • TABLE 33 HEALTHCARE ANALYTICS MARKET FOR PAYMENT INTEGRITY & FWA, BY REGION, 2020-2027 (USD MILLION)
    • 9.2.4 RISK ADJUSTMENT & ASSESSMENT
      • 9.2.4.1 Optimization of cash flows and improved financial performance to aid market
    • TABLE 34 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS
    • TABLE 35 HEALTHCARE ANALYTICS MARKET FOR RISK ADJUSTMENT & ASSESSMENT, BY REGION, 2020-2027 (USD MILLION)
  • 9.3 CLINICAL ANALYTICS
    • TABLE 36 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS
    • TABLE 37 HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 38 HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY REGION, 2020-2027 (USD MILLION)
    • 9.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
      • 9.3.1.1 Benchmarking to identify and manage issues that negatively impact healthcare systems
    • TABLE 39 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL BENCHMARKING SOLUTIONS
    • TABLE 40 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 9.3.2 CLINICAL DECISION SUPPORT
      • 9.3.2.1 Reduction of medical errors and performance of appropriate tests to augment market
    • TABLE 41 COMMERCIALLY AVAILABLE SOLUTIONS FOR CLINICAL DECISION SUPPORT
    • TABLE 42 CLINICAL DECISION SUPPORT MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 9.3.3 REPORTING & COMPLIANCE
      • 9.3.3.1 Stringent regulatory requirements to accelerate market
    • TABLE 43 COMMERCIALLY AVAILABLE SOLUTIONS FOR REPORTING & COMPLIANCE
    • TABLE 44 REPORTING & COMPLIANCE MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 9.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS
      • 9.3.4.1 Growing adoption of EHRs to provide growth
    • TABLE 45 COMMERCIALLY AVAILABLE SOLUTIONS FOR COMPARATIVE ANALYTICS/EFFECTIVENESS
    • TABLE 46 COMPARATIVE ANALYTICS/EFFECTIVENESS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 9.3.5 PRECISION HEALTH
      • 9.3.5.1 Strong government support for personalized medicine to drive market
    • TABLE 47 COMMERCIALLY AVAILABLE PRECISION HEALTH SOLUTIONS
    • TABLE 48 PRECISION HEALTH MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 9.3.6 MEDICAL IMAGING ANALYTICS
      • 9.3.6.1 Imaging analytics aided by artificial intelligence and machine learning to fuel market
    • TABLE 49 COMMERCIALLY AVAILABLE SOLUTIONS FOR MEDICAL IMAGING ANALYTICS
    • TABLE 50 MEDICAL IMAGING ANALYTICS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS
    • TABLE 51 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS
    • TABLE 52 HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 53 HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY REGION, 2020-2027 (USD MILLION)
    • 9.4.1 SUPPLY CHAIN ANALYTICS
      • 9.4.1.1 Informed decisions about costs, medication, and equipment to propel market
    • TABLE 54 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS
    • TABLE 55 SUPPLY CHAIN ANALYTICS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 9.4.2 WORKFORCE ANALYTICS
      • 9.4.2.1 Need for real-time resource demand and supply data to drive adoption of workforce analytics
    • TABLE 56 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS
    • TABLE 57 WORKFORCE ANALYTICS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 9.4.3 STRATEGIC ANALYTICS
      • 9.4.3.1 Strategic analytics to use advanced analytics tools and leverage operational data
    • TABLE 58 STRATEGIC ANALYTICS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.5 POPULATION HEALTH ANALYTICS
    • 9.5.1 IMPROVING POPULATION HEALTH OUTCOMES AND LOWERING COSTS TO DRIVE GROWTH
    • TABLE 59 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS
    • TABLE 60 HEALTHCARE ANALYTICS MARKET FOR POPULATION HEALTH ANALYTICS, BY REGION, 2020-2027 (USD MILLION)

10 HEALTHCARE ANALYTICS MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 61 HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.2 PAYERS
    • TABLE 62 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 63 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY REGION, 2020-2027 (USD MILLION)
    • 10.2.1 PRIVATE INSURANCE COMPANIES
      • 10.2.1.1 Private insurance companies to account for largest market share
    • TABLE 64 PRIVATE INSURANCE COMPANIES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 10.2.2 GOVERNMENT AGENCIES
      • 10.2.2.1 Increasing use of analytics solutions to boost market
    • TABLE 65 GOVERNMENT AGENCIES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 10.2.3 EMPLOYERS & PRIVATE EXCHANGES
      • 10.2.3.1 Employers & private exchanges to use data analytics for rapid data integration, health plan analysis, and risk modeling
    • TABLE 66 EMPLOYERS & PRIVATE EXCHANGES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.3 PROVIDERS
    • TABLE 67 HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS
      • 10.3.1.1 Adoption of healthcare analytics solutions to drive growth
    • TABLE 68 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 10.3.2 POST-ACUTE CARE ORGANIZATIONS
      • 10.3.2.1 Post-acute care organizations to review and study patient data using healthcare analytics
    • TABLE 69 POST-ACUTE CARE ORGANIZATIONS MARKET, BY REGION,2020-2027 (USD MILLION)
    • 10.3.3 AMBULATORY SETTINGS
      • 10.3.3.1 Management of population health and need to control healthcare costs to support market
    • TABLE 70 AMBULATORY SETTINGS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.4 ACOS, HIES, MCOS, AND TPAS
    • TABLE 71 HEALTHCARE ANALYTICS MARKET FOR ACOS, HIES, MCOS, AND TPAS, BY REGION, 2020-2027 (USD MILLION)

11 HEALTHCARE ANALYTICS MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 72 HEALTHCARE ANALYTICS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 31 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021)
    • TABLE 73 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 74 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 75 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 76 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027(USD MILLION)
    • TABLE 77 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 78 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 79 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 80 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 81 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 82 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 83 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 84 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 High adoption of EHRs to drive market
    • TABLE 85 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 86 US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 87 US: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 88 US: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 89 US: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 90 US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 91 US: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 92 US: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 93 US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 94 US: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 95 US: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Need for managing patient volumes, clinical data, and healthcare costs to fuel market
    • TABLE 96 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 97 CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 98 CANADA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 99 CANADA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 100 CANADA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 101 CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 102 CANADA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 103 CANADA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 104 CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 105 CANADA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 106 CANADA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 11.3 EUROPE
    • FIGURE 32 EUROPE: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021)
    • TABLE 107 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 108 EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027(USD MILLION)
    • TABLE 109 EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 110 EUROPE: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 111 EUROPE: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 112 EUROPE: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 113 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 114 EUROPE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 115 EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 116 EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 117 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 118 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 Government initiatives to increase use of analytics in healthcare
    • TABLE 119 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 120 GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 121 GERMANY: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027(USD MILLION)
    • TABLE 122 GERMANY: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 123 GERMANY: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 124 GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 125 GERMANY: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 126 GERMANY: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 127 GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 128 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 129 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 11.3.2 UK
      • 11.3.2.1 Availability of venture capital investments to drive market
    • TABLE 130 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 131 UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 132 UK: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 133 UK: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 134 UK: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 135 UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 136 UK: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 137 UK: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 138 UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 139 UK: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 140 UK: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Strong financial support for digital health to augment market
    • TABLE 141 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 142 FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 143 FRANCE: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 144 FRANCE: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 145 FRANCE: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 146 FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 147 FRANCE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 148 FRANCE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 149 FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 150 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 151 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 11.3.4 REST OF EUROPE
    • TABLE 152 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 153 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 154 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027(USD MILLION)
    • TABLE 155 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 156 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 157 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 158 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 159 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 160 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 161 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 162 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 11.4 ASIA
    • FIGURE 33 ASIA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021)
    • TABLE 163 ASIA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 164 ASIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 165 ASIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 166 ASIA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 167 ASIA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027(USD MILLION)
    • TABLE 168 ASIA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 169 ASIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 170 ASIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 171 ASIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 172 ASIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 173 ASIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 174 ASIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 11.4.1 JAPAN
      • 11.4.1.1 Rise in geriatric population to demand effective patient management solutions
    • TABLE 175 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 176 JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 177 JAPAN: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 178 JAPAN: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 179 JAPAN: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 180 JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 181 JAPAN: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 182 JAPAN: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 183 JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 184 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 185 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 Favorable reforms and growing number of EHRs to aid market
    • TABLE 186 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 187 CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 188 CHINA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 189 CHINA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 190 CHINA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 191 CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 192 CHINA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 193 CHINA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 194 CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 195 CHINA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 196 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 Low healthcare expenditure by government and slow adoption of healthcare analytics solutions to restrain market
    • TABLE 197 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 198 INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 199 INDIA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 200 INDIA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 201 INDIA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 202 INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 203 INDIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 204 INDIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 205 INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 206 INDIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 207 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
    • 11.4.4 REST OF ASIA
    • TABLE 208 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 209 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 210 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 211 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 212 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 213 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 214 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 215 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 216 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 217 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 218 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 11.5 PACIFIC COUNTRIES
    • 11.5.1 NEED TO REDUCE HEALTHCARE COSTS IN AUSTRALIA AND NEW ZEALAND TO DRIVE MARKET
    • TABLE 219 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 220 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 221 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 222 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027(USD MILLION)
    • TABLE 223 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 224 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 225 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 226 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 227 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 228 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 229 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 11.6 LATIN AMERICA
    • 11.6.1 GROWING E-HEALTH INITIATIVES TO PROPEL MARKET
    • TABLE 230 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 231 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 232 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 233 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 234 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 235 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 236 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 237 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 238 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 239 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 240 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)
  • 11.7 MIDDLE EAST & AFRICA
    • 11.7.1 HIGH HEALTHCARE EXPENDITURE AND INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET
    • TABLE 241 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 242 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 243 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 244 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020-2027(USD MILLION)
    • TABLE 245 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 246 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 247 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 248 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2027 (USD MILLION)
    • TABLE 249 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 250 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 251 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020-2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
  • 12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICS MARKET
  • 12.4 MARKET RANKING ANALYSIS, 2021
    • FIGURE 35 HEALTHCARE ANALYTICS MARKET RANKING ANALYSIS, 2021
  • 12.5 COMPANY LEADERSHIP MAPPING
    • 12.5.1 STARS
    • 12.5.2 PERVASIVE PLAYERS
    • 12.5.3 EMERGING LEADERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 36 HEALTHCARE ANALYTICS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
  • 12.6 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES (2021)
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 STARTING BLOCKS
    • 12.6.3 RESPONSIVE COMPANIES
    • 12.6.4 DYNAMIC COMPANIES
    • FIGURE 37 HEALTHCARE ANALYTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
  • 12.7 COMPETITIVE BENCHMARKING
    • FIGURE 38 OVERALL FOOTPRINT OF COMPANIES (17 COMPANIES)
    • TABLE 252 APPLICATION FOOTPRINT OF COMPANIES
    • TABLE 253 END-USER FOOTPRINT OF COMPANIES
    • TABLE 254 REGIONAL FOOTPRINT OF COMPANIES
  • 12.8 COMPETITIVE SCENARIO
    • 12.8.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 255 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2019-OCTOBER 2022
    • 12.8.2 DEALS
    • TABLE 256 DEALS, JANUARY 2019-OCTOBER 2022
    • 12.8.3 OTHER DEVELOPMENTS
    • TABLE 257 OTHER DEVELOPMENTS, JANUARY 2019-OCTOBER 2022

13 COMPANY PROFILES

  • (Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)**
  • 13.1 KEY PLAYERS
    • 13.1.1 IBM
    • TABLE 258 IBM: COMPANY OVERVIEW
    • FIGURE 39 IBM: COMPANY SNAPSHOT (2021)
    • 13.1.2 SAS INSTITUTE INC.
    • TABLE 259 SAS INSTITUTE INC.: COMPANY OVERVIEW
    • FIGURE 40 SAS INSTITUTE INC.: COMPANY SNAPSHOT (2021)
    • 13.1.3 OPTUM, INC.
    • TABLE 260 OPTUM, INC.: COMPANY OVERVIEW
    • FIGURE 41 OPTUM, INC.: COMPANY SNAPSHOT (2021)
    • 13.1.4 CERNER CORPORATION
    • TABLE 261 CERNER CORPORATION: COMPANY OVERVIEW
    • FIGURE 42 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
    • 13.1.5 ALLSCRIPTS HEALTHCARE, LLC
    • TABLE 262 ALLSCRIPTS HEALTHCARE, LLC: COMPANY OVERVIEW
    • FIGURE 43 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
    • 13.1.6 COTIVITI, INC.
    • TABLE 263 COTIVITI, INC.: COMPANY OVERVIEW
    • 13.1.7 CITIUSTECH INC.
    • TABLE 264 CITIUSTECH INC.: COMPANY OVERVIEW
    • 13.1.8 HEALTH CATALYST
    • TABLE 265 HEALTH CATALYST: COMPANY OVERVIEW
    • FIGURE 44 HEALTH CATALYST: COMPANY SNAPSHOT (2021)
    • 13.1.9 CVS HEALTH
    • TABLE 266 CVS HEALTH: COMPANY OVERVIEW
    • FIGURE 45 CVS HEALTH: COMPANY SNAPSHOT (2021)
    • 13.1.10 INOVALON
    • TABLE 267 INOVALON: COMPANY OVERVIEW
    • FIGURE 46 INOVALON: COMPANY SNAPSHOT (2021)
    • 13.1.11 MCKESSON CORPORATION
    • TABLE 268 MCKESSON CORPORATION: COMPANY OVERVIEW
    • FIGURE 47 MCKESSON CORPORATION.: COMPANY SNAPSHOT (2021)
    • 13.1.12 MEDEANALYTICS, INC.
    • TABLE 269 MEDEANALYTICS, INC.: COMPANY OVERVIEW
    • 13.1.13 ORACLE
    • TABLE 270 ORACLE: COMPANY OVERVIEW
    • FIGURE 48 ORACLE: COMPANY SNAPSHOT (2022)
    • 13.1.14 EXLSERVICE HOLDINGS, INC.
    • TABLE 271 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW
    • FIGURE 49 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2021)
    • 13.1.15 GAINWELL.
    • TABLE 272 GAINWELL: COMPANY OVERVIEW
    • 13.1.16 WIPRO
    • TABLE 273 WIPRO: COMPANY OVERVIEW
    • FIGURE 50 WIPRO: COMPANY SNAPSHOT (2022)
  • 13.2 OTHER PLAYERS
    • 13.2.1 FLATIRON
    • TABLE 274 FLATIRON: COMPANY OVERVIEW
    • 13.2.2 APIXIO
    • TABLE 275 APIXIO: COMPANY OVERVIEW
    • 13.2.3 ENLITIC, INC.
    • TABLE 276 ENLITIC, INC.: COMPANY OVERVIEW
    • 13.2.4 KOMODO HEALTH, INC.
    • TABLE 277 KOMODO HEALTH, INC.: COMPANY OVERVIEW
    • 13.2.5 HEALTHEC, LLC
    • TABLE 278 HEALTHEC, LLC: COMPANY OVERVIEW
    • 13.2.6 SEMA4 OPCO, INC.
    • 13.2.7 EVIDATION HEALTH, INC.
    • 13.2.8 INSILICO MEDICINE
    • 13.2.9 EXSCIENTIA
    • 13.2.10 AETION, INC.
    • 13.2.11 PREMIER
  • *Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS